- Home
- OSUR vs CRBU Comparison
OSUR vs CRBU Comparison
Compare OSUR & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CRBU
- Stock Information
- Founded
- OSUR 2000
- CRBU 2011
- Country
- OSUR United States
- CRBU United States
- Employees
- OSUR N/A
- CRBU N/A
- Industry
- OSUR Medical/Dental Instruments
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- OSUR Health Care
- CRBU Health Care
- Exchange
- OSUR Nasdaq
- CRBU Nasdaq
- Market Cap
- OSUR 233.4M
- CRBU 188.8M
- IPO Year
- OSUR 1986
- CRBU 2021
- Fundamental
- Price
- OSUR $2.77
- CRBU $2.00
- Analyst Decision
- OSUR Hold
- CRBU Strong Buy
- Analyst Count
- OSUR 1
- CRBU 3
- Target Price
- OSUR $3.00
- CRBU $6.67
- AVG Volume (30 Days)
- OSUR 553.7K
- CRBU 1.7M
- Earning Date
- OSUR 08-05-2025
- CRBU 08-12-2025
- Dividend Yield
- OSUR N/A
- CRBU N/A
- EPS Growth
- OSUR N/A
- CRBU N/A
- EPS
- OSUR N/A
- CRBU N/A
- Revenue
- OSUR $138,533,000.00
- CRBU $9,121,000.00
- Revenue This Year
- OSUR N/A
- CRBU $9.52
- Revenue Next Year
- OSUR $6.80
- CRBU N/A
- P/E Ratio
- OSUR N/A
- CRBU N/A
- Revenue Growth
- OSUR N/A
- CRBU N/A
- 52 Week Low
- OSUR $2.36
- CRBU $0.66
- 52 Week High
- OSUR $4.61
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- OSUR 36.84
- CRBU 55.64
- Support Level
- OSUR $2.75
- CRBU $1.62
- Resistance Level
- OSUR $2.96
- CRBU $2.13
- Average True Range (ATR)
- OSUR 0.15
- CRBU 0.18
- MACD
- OSUR -0.05
- CRBU -0.04
- Stochastic Oscillator
- OSUR 14.29
- CRBU 55.07
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.